|
Sung HJ, Johnson CE, Lessner SM, Magid R, Drury DN and
Galis ZS. Matrix metalloproteinase 9 facilitates collagen remodeling and
angiogenesis for vascular constructs. Tissue Eng 11: 267-276, 2005.
Sung HJ, Su J, Berglund JD, Russ BV, Meredith JC and Galis ZS. The use
of temperature-composition combinatorial libraries to study the effects of
biodegradable polymer blend surfaces on vascular cells. Biomaterials
26: 4557-4567, 2005.
Lessner SM, Martinson DE and Galis ZS. Compensatory vascular remodeling
during atherosclerotic lesion growth depends on matrix metalloproteinase-9
activity. Arterioscler Thromb Vasc Biol 24: 2123-2129, 2004.
Galis ZS. Vulnerable plaque: the devil is in the details.
Circulation 110: 244-246, 2004.
Sung HJ, Meredith C, Johnson C and Galis ZS. The effect of scaffold
degradation rate on three-dimensional cell growth and angiogenesis.
Biomaterials 25: 5735-5742, 2004.
Lessner SM and Galis ZS. Matrix metalloproteinases and vascular
endothelium-mononuclear cell close encounters. Trends Cardiovasc Med
14: 105-111, 2004.
Kim SH, Lessner SM, Sakurai Y and Galis ZS. Cyclophilin A as a novel
biphasic mediator of endothelial activation and dysfunction. Am J
Pathol 164: 1567-1574, 2004.
Pasterkamp G, Galis ZS and de Kleijn DP. Expansive arterial remodeling:
location, location, location. Arterioscler Thromb Vasc Biol 24:
650-657, 2004.
Khatri JJ, Johnson C, Magid R, Lessner SM, Laude KM, Dikalov SI,
Harrison DG, Sung HJ, Rong Y and Galis ZS. Vascular oxidant stress
enhances progression and angiogenesis of experimental atheroma.
Circulation 109: 520-525, 2004.
Johnson C, Sung HJ, Lessner SM, Fini ME and Galis ZS. Matrix
metalloproteinase-9 is required for adequate angiogenic revascularization
of ischemic tissues: potential role in capillary branching. Circ Res
94: 262-268, 2004.
Johnson C and Galis ZS. Quantitative assessment of collagen assembly by
live cells. J Biomed Mater Res A 67: 775-784, 2003.
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J,
Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH,
Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ,
Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR,
Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA,
March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM,
Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Jr., Schwartz
RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H,
Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK and
Willerson JT. From vulnerable plaque to vulnerable patient: a call for new
definitions and risk assessment strategies: Part II. Circulation
108: 1772-1778, 2003.
Johnson C and Galis ZS. Matrix metalloproteinase-2 and -9
differentially regulate smooth muscle cell migration and cell-mediated
collagen organization. Arterioscler Thromb Vasc Biol 24: 54-60,
2004.
Berglund JD and Galis ZS. Designer blood vessels and therapeutic
revascularization. Br J Pharmacol 140: 627-636, 2003.
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J,
Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH,
Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ,
Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G,
Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W,
Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R,
Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Jr.,
Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H,
Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK and
Willerson JT. From vulnerable plaque to vulnerable patient: a call for new
definitions and risk assessment strategies: Part I. Circulation
108: 1664-1672, 2003.
Seliktar D, Nerem RM and Galis ZS. Mechanical strain-stimulated
remodeling of tissue-engineered blood vessel constructs. Tissue Eng
9: 657-666, 2003.
Magid R, Murphy TJ and Galis ZS. Expression of matrix
metalloproteinase-9 in endothelial cells is differentially regulated by
shear stress. Role of c-Myc. J Biol Chem 278: 32994-32999, 2003.
Burke AP, Virmani R, Galis Z, Haudenschild CC and Muller JE. 34th
Bethesda Conference: Task force #2--What is the pathologic basis for new
atherosclerosis imaging techniques? J Am Coll Cardiol 41:
1874-1886, 2003.
Magid R, Martinson D, Hwang J, Jo H and Galis ZS. Optimization of
isolation and functional characterization of primary murine aortic
endothelial cells. Endothelium 10: 103-109, 2003.
Asanuma K, Magid R, Johnson C, Nerem RM and Galis ZS. Uniaxial strain
upregulates matrix-degrading enzymes produced by human vascular smooth
muscle cells. Am J Physiol Heart Circ Physiol 284: H1778-H1784,
2003.
Roman J and Galis ZS. Sarcoidosis: a mysterious tale of inflammation,
tissue remodeling, and matrix metalloproteinases. Hum Pathol 33:
1155-1157, 2002.
Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM and Ivan
E. Targeted disruption of the matrix metalloproteinase-9 gene impairs
smooth muscle cell migration and geometrical arterial remodeling. Circ
Res 91: 852-859, 2002.
Lessner SM, Prado HL, Waller EK and Galis ZS. Atherosclerotic lesions
grow through recruitment and proliferation of circulating monocytes in a
murine model. Am J Pathol 160: 2145-2155, 2002.
Ivan E, Khatri JJ, Johnson C, Magid R, Godin D, Nandi S, Lessner S and
Galis ZS. Expansive arterial remodeling is associated with increased
neointimal macrophage foam cell content: the murine model of
macrophage-rich carotid artery lesions. Circulation 105: 2686-2691,
2002.
Galis ZS and Khatri JJ. Matrix metalloproteinases in vascular
remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res
90: 251-262, 2002.
Seliktar D, Nerem RM and Galis ZS. The role of matrix
metalloproteinase-2 in the remodeling of cell-seeded vascular constructs
subjected to cyclic strain. Ann Biomed Eng 29: 923-934, 2001.
Shah PK and Galis ZS. Matrix metalloproteinase hypothesis of plaque
rupture: players keep piling up but questions remain. Circulation
104: 1878-1880, 2001.
Mavromatis K, Fukai T, Tate M, Chesler N, Ku DN and Galis ZS. Early
effects of arterial hemodynamic conditions on human saphenous veins
perfused ex vivo. Arterioscler Thromb Vasc Biol 20: 1889-1895,
2000.
Somers MJ, Mavromatis K, Galis ZS and Harrison DG. Vascular superoxide
production and vasomotor function in hypertension induced by
deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
Galis ZS. Atheroma morphology and mechanical strength: looks are
important, after all--lose the fat. Circ Res 86: 1-3, 2000.
Godin D, Ivan E, Johnson C, Magid R and Galis ZS. Remodeling of carotid
artery is associated with increased expression of matrix
metalloproteinases in mouse blood flow cessation model. Circulation
102: 2861-2866, 2000.
Chesler NC, Ku DN and Galis ZS. Transmural pressure induces
matrix-degrading activity in porcine arteries ex vivo. Am J Physiol
277: H2002-H2009, 1999.
Meng X, Mavromatis K and Galis ZS. Mechanical stretching of human
saphenous vein grafts induces expression and activation of
matrix-degrading enzymes associated with vascular tissue injury and
repair. Exp Mol Pathol 66: 227-237, 1999.
Coker ML, Doscher MA, Thomas CV, Galis ZS and Spinale FG . Matrix
metalloproteinase synthesis and expression in isolated LV myocyte
preparations. Am J Physiol 277: H777-H787, 1999.
Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J,
Chai NN, Xu XP, Jovinge S, Shah PK and Libby P. Inflammatory cytokines and
oxidized low density lipoproteins increase endothelial cell expression of
membrane type 1-matrix metalloproteinase. J Biol Chem 274:
11924-11929, 1999.
Li Z, Froehlich J, Galis ZS and Lakatta EG. Increased expression of
matrix metalloproteinase-2 in the thickened intima of aged rats.
Hypertension 33: 116-123, 1999.
Galis ZS, Asanuma K, Godin D and Meng X. N-acetyl-cysteine decreases
the matrix-degrading capacity of macrophage-derived foam cells: new target
for antioxidant therapy? Circulation 97: 2445-2453, 1998.
Coker ML, Thomas CV, Clair MJ, Hendrick JW, Krombach RS, Galis ZS and
Spinale FG. Myocardial matrix metalloproteinase activity and abundance
with congestive heart failure. Am J Physiol 274: H1516-H1523, 1998.
Fukai T, Galis ZS, Meng XP, Parthasarathy S and Harrison DG. Vascular
expression of extracellular superoxide dismutase in atherosclerosis. J
Clin Invest 101: 2101-2111, 1998.
Wesley RB, Meng X, Godin D and Galis ZS. Extracellular matrix modulates
macrophage functions characteristic to atheroma: collagen type I enhances
acquisition of resident macrophage traits by human peripheral blood
monocytes in vitro. Arterioscler Thromb Vasc Biol 18: 432-440,
1998.
Galis ZS, Kranzhofer R, Fenton JW and Libby P. Thrombin promotes
activation of matrix metalloproteinase-2 produced by cultured vascular
smooth muscle cells. Arterioscler Thromb Vasc Biol 17: 483-489,
1997.
Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA and Harrison
DG. Role of superoxide in angiotensin II-induced but not
catecholamine-induced hypertension. Circulation 95: 588-593, 1997.
Rajagopalan S, Meng XP, Ramasamy S, Harrison DG and Galis ZS. Reactive
oxygen species produced by macrophage-derived foam cells regulate the
activity of vascular matrix metalloproteinases in vitro. Implications for
atherosclerotic plaque stability. J Clin Invest 98: 2572-2579,
1996.
Galis ZS, Sukhova GK and Libby P. Microscopic localization of active
proteases by in situ zymography: detection of matrix metalloproteinase
activity in vascular tissue. FASEB J 9: 974-980, 1995.
Galis ZS, Sukhova GK, Kranzhofer R, Clark S and Libby P. Macrophage
foam cells from experimental atheroma constitutively produce
matrix-degrading proteinases. Proc Natl Acad Sci U S A 92: 402-406,
1995.
Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E and Libby P.
Enhanced expression of vascular matrix metalloproteinases induced in vitro
by cytokines and in regions of human atherosclerotic lesions. Ann N Y
Acad Sci 748: 501-507, 1995.
Libby P and Galis ZS. Cytokines regulate genes involved in
atherogenesis. Ann N Y Acad Sci 748: 158-168, 1995.
Libby P, Sukhova G, Lee RT and Galis ZS. Cytokines regulate vascular
functions related to stability of the atherosclerotic plaque. J
Cardiovasc Pharmacol 25 Suppl 2: S9-12, 1995.
Galis ZS, Sukhova GK, Lark MW and Libby P. Increased expression of
matrix metalloproteinases and matrix degrading activity in vulnerable
regions of human atherosclerotic plaques. J Clin Invest 94:
2493-2503, 1994.
Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark
MW, Amento E and Libby P. Cytokine-stimulated human vascular smooth muscle
cells synthesize a complement of enzymes required for extracellular matrix
digestion. Circ Res 75: 181-189, 1994.
Galis ZS, Alavi MZ and Moore S. Co-localization of aortic
apolipoprotein B and chondroitin sulfate in an injury model of
atherosclerosis. Am J Pathol 142: 1432-1438, 1993.
Li Z, Alavi MZ, Wasty F, Galis Z and Moore S. Proteoglycan synthesis by
the neointimal smooth muscle cells cultured from rabbit aortic explants
following de-endothelialization. Pathobiology 61: 89-94, 1993.
Galis ZS, Alavi MZ and Moore S. Sulfated proteoglycans of rabbit aorta:
selective extraction and alternative method for glycosaminoglycan moiety
analysis. Anal Biochem 204: 390-397, 1992.
Alavi MZ, Wasty F, Li Z, Galis ZS, Ismail N and Moore S. Enhanced
incorporation of [14C]glucosamine into glycosaminoglycans of aortic
neointima of balloon-injured and cholesterol-fed rabbits in vitro.
Atherosclerosis 95: 59-67, 1992.
Galis ZS, Ghitescu LD, Li Z, Alavi MZ and Moore S. Distribution of
endogenous apoprotein B-containing lipoproteins in normal and injured
aortas of normocholesterolemic rabbits. Lab Invest 66: 624-638,
1992.
Galis ZS, Alavi MZ and Moore S. In situ ultrastructural
characterization of chondroitin sulfate proteoglycans in normal rabbit
aorta. J Histochem Cytochem 40: 251-263, 1992.
Alavi MZ, Galis Z, Li ZH and Moore S. Dietary alterations of plasma
lipoproteins influence their interactions with proteoglycan enriched
extracts from neointima of normal and injured aorta of rabbit. Clin
Invest Med 14: 419-431, 1991.
Ghitescu L, Galis Z and Bendayan M. Protein AG-gold complex: an
alternative probe in immunocytochemistry. J Histochem Cytochem 39:
1057-1065, 1991.
Galis Z, Ghitescu L and Simionescu M. Fatty acids binding to albumin
increases its uptake and transcytosis by the lung capillary endothelium.
Eur J Cell Biol 47: 358-365, 1988.
Ghitescu L, Galis Z, Simionescu M and Simionescu N. Differentiated
uptake and transcytosis of albumin in successive vascular segments. J
Submicrosc Cytol Pathol 20: 657-669, 1988.
Tasca SI and Galis Z. Ultrastructural autoradiographic localization of
exogenous arachidonic acid in cultured endothelial and smooth muscle
cells. Prostaglandins Leukot Essent Fatty Acids 33: 165-171, 1988.
|
Copyright © 2000 University Vascular Surgeons
Created by: Jason Unthank
Last Updated:
January 03, 2007
Comments: comments@iuvascular.com
URL: http://www.iuvascular.com/Faculty/ZSGjournals.html